This topic contains a solution. Click here to go to the answer

Author Question: The client who has received intravenous immune globulin must wait what length of time before ... (Read 109 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
The client who has received intravenous immune globulin must wait what length of time before receiving active immunization?
 
  1. 2 months
  2. 1 year
  3. 4 months
  4. 1 month

Question 2

The nurse correctly understands that the administration of the PCV vaccine should occur at which ages?
 
  1. 5 and 10 months
  2. 15 and 18 months
  3. 1, 8, 13, and 18 to 20 months
  4. 2, 4, 6, and 12 to 15 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bhavsar

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

Correct Answer: 3
Rationale 1: Two months is not long enough.
Rationale 2: One year is too long to wait for additional immunizations.
Rationale 3: The client must wait at least 3 to 5 months.
Rationale 4: One month is not long enough.
Global Rationale: Because this drug contains antibodies to live viruses, active vaccinations should not be given until 3 to 5 months after IVIG has been administered.

Answer to Question 2

Correct Answer: 4
Rationale 1: This is not the time frame for PCV administration.
Rationale 2: This is not the time frame for PCV administration.
Rationale 3: This is not the time frame for PCV administration.
Rationale 4: The PCV vaccine should be administered at 2, 4, 6, and 12 to 15 months.
Global Rationale: Because the administration of PPV to young children with immature immune systems leads to a poor antibody response, this vaccine is not recommended in children under 2 years of age. A second vaccine, called pneumococcal conjugate vaccine (PCV), was specially developed for routine immunization in children under the age of 2. This immunization differs from PPV in that the S. pneumoniae polysaccharides are coupled with a protein that leads to improved immune activation in infants with immature immune function. The latest form of the pneumococcal conjugate vaccine, PCV13, was approved in 2010 and protects against 13 types of pneumococcal bacteria. PCV13 is used in a series of four IM injections at 2 months, 4 months, 6 months, and 12 to 15 months.




tingc95

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Gracias!


cpetit11

  • Member
  • Posts: 321
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library